Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Imoto

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
FEBS Letters|February 11, 1991
Induction of morphological change by tyrosine kinase inhibitors in Rous sarcoma virus-transformed rat kidney cellsK Umezawa, K Tanaka, T Hori, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 9, 2011
Evaluation for activities of component of Cyclotron-Based Epithermal Neutron Source (C-BENS) and the surface of concrete wall in irradiation roomM Imoto, H Tanaka, K Fujita, et al.
The Journal of Antibiotics|February 1, 1992
Inhibition of tyrosine kinase and src oncogene functions by stable erbstatin analoguesT Hori, T Kondo, T Tsuji, et al.
The Journal of Antibiotics|August 1, 1987
Effective synthesis of erbstatin and its analogsK Isshiki, M Imoto, T Takeuchi, et al.
The Journal of Antibiotics|October 1, 1987
Kinetic studies of tyrosine kinase inhibition by erbstatinM Imoto, K Umezawa, K Isshiki, et al.
The Journal of Antibiotics|August 31, 2000
MK800-62F1, a new inhibitor of apoptotic cell death, from Streptomyces diastatochromogenes MK800-62F1. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activityY Yoshimoto, T Sawa, N Kinoshita, et al.
Journal of Gastroenterology and Hepatology|November 1, 1994
High rate of mixed genotypes of hepatitis C virus in patients of an epidemic area in JapanM Yamada, Y Fukuda, M Imoto, et al.
Liver|June 1, 1995
Hepatitis C virus infection and genotypes in Japanese hemophiliacsK Isobe, M Imoto, Y Fukuda, et al.
The Journal of Antibiotics|February 1, 1986
The structure of an epidermal growth factor-receptor kinase inhibitor, erbstatinH Nakamura, Y Iitaka, M Imoto, et al.
The American Journal of Gastroenterology|June 1, 1989
In situ distribution of enolase isozymes in chronic liver diseaseY Fukuda, Y Miyazawa, M Imoto, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
FEBS Letters|February 11, 1991
Induction of morphological change by tyrosine kinase inhibitors in Rous sarcoma virus-transformed rat kidney cellsK Umezawa, K Tanaka, T Hori, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 9, 2011
Evaluation for activities of component of Cyclotron-Based Epithermal Neutron Source (C-BENS) and the surface of concrete wall in irradiation roomM Imoto, H Tanaka, K Fujita, et al.
The Journal of Antibiotics|February 1, 1992
Inhibition of tyrosine kinase and src oncogene functions by stable erbstatin analoguesT Hori, T Kondo, T Tsuji, et al.
The Journal of Antibiotics|August 1, 1987
Effective synthesis of erbstatin and its analogsK Isshiki, M Imoto, T Takeuchi, et al.
The Journal of Antibiotics|October 1, 1987
Kinetic studies of tyrosine kinase inhibition by erbstatinM Imoto, K Umezawa, K Isshiki, et al.
The Journal of Antibiotics|August 31, 2000
MK800-62F1, a new inhibitor of apoptotic cell death, from Streptomyces diastatochromogenes MK800-62F1. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activityY Yoshimoto, T Sawa, N Kinoshita, et al.
Journal of Gastroenterology and Hepatology|November 1, 1994
High rate of mixed genotypes of hepatitis C virus in patients of an epidemic area in JapanM Yamada, Y Fukuda, M Imoto, et al.
Liver|June 1, 1995
Hepatitis C virus infection and genotypes in Japanese hemophiliacsK Isobe, M Imoto, Y Fukuda, et al.
The Journal of Antibiotics|February 1, 1986
The structure of an epidermal growth factor-receptor kinase inhibitor, erbstatinH Nakamura, Y Iitaka, M Imoto, et al.
The American Journal of Gastroenterology|June 1, 1989
In situ distribution of enolase isozymes in chronic liver diseaseY Fukuda, Y Miyazawa, M Imoto, et al.
Pageof 14